{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:19:57Z","timestamp":1773922797663,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T00:00:00Z","timestamp":1526256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2016YFC0904100"],"award-info":[{"award-number":["2016YFC0904100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81570598"],"award-info":[{"award-number":["No. 81570598"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Shanghai Natural Science Foundation","doi-asserted-by":"crossref","award":["15ZR1426300"],"award-info":[{"award-number":["15ZR1426300"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s10157-018-1585-z","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T01:31:58Z","timestamp":1526261518000},"page":"1315-1323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria"],"prefix":"10.1007","volume":"22","author":[{"given":"Jianni","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingyan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,14]]},"reference":[{"issue":"2","key":"1585_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000442999","volume":"132","author":"S Bagchi","year":"2016","unstructured":"Bagchi S, Agarwal S, Kalaivani M, Bhowmik D, Singh G, Mahajan S, et al. Primary FSGS in Nephrotic Adults: Clinical Profile, Response to Immunosuppression and Outcome. Nephron. 2016;132(2):81\u20135. \n                    https:\/\/doi.org\/10.1159\/000442999\n                    \n                  .","journal-title":"Nephron"},{"issue":"2","key":"1585_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/0971-4065.127892","volume":"24","author":"M Rathi","year":"2014","unstructured":"Rathi M, Bhagat RL, Mukhopadhyay P, Kohli HS, Jha V, Gupta KL, et al. Changing histologic spectrum of adult nephrotic syndrome over five decades in north India: a single center experience. Indian J Nephrol. 2014;24(2):86\u201391. \n                    https:\/\/doi.org\/10.4103\/0971-4065.127892\n                    \n                  .","journal-title":"Indian J Nephrol"},{"issue":"2","key":"1585_CR3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/ndt\/gfp355","volume":"25","author":"MG Polito","year":"2010","unstructured":"Polito MG, de Moura LA, Kirsztajn GM. An overview on frequency of renal biopsy diagnosis in Brazil: clinical and pathological patterns based on 9,617 native kidney biopsies. Nephrol Dial Transplant. 2010;25(2):490\u20136. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfp355\n                    \n                  .","journal-title":"Nephrol Dial Transplant"},{"key":"1585_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000348642","volume":"181","author":"J Xie","year":"2013","unstructured":"Xie J, Chen N. Primary glomerulonephritis in mainland China: an overview. Contrib Nephrol. 2013;181:1\u201311. \n                    https:\/\/doi.org\/10.1159\/000348642\n                    \n                  .","journal-title":"Contrib Nephrol"},{"issue":"11","key":"1585_CR5","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1681\/ASN.2012040389","volume":"23","author":"SM Korbet","year":"2012","unstructured":"Korbet SM. Treatment of primary FSGS in adults. J Am Soc Nephrol. 2012;23(11):1769\u201376. \n                    https:\/\/doi.org\/10.1681\/ASN.2012040389\n                    \n                  .","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1585_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5414\/CN107607","volume":"80","author":"X Tang","year":"2013","unstructured":"Tang X, Xu F, Chen DM, Zeng CH, Liu ZH. The clinical course and long-term outcome of primary focal segmental glomerulosclerosis in Chinese adults. Clin Nephrol. 2013;80(2):130\u20139. \n                    https:\/\/doi.org\/10.5414\/CN107607\n                    \n                  .","journal-title":"Clin Nephrol"},{"issue":"7","key":"1585_CR7","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.2215\/CJN.11261114","volume":"10","author":"MM O\u2019Shaughnessy","year":"2015","unstructured":"O\u2019Shaughnessy MM, Montez-Rath ME, Lafayette RA, Winkelmayer WC. Patient characteristics and outcomes by GN subtype in ESRD. Clin J Am Soc Nephrol. 2015;10(7):1170\u20138. \n                    https:\/\/doi.org\/10.2215\/CJN.11261114\n                    \n                  .","journal-title":"Clin J Am Soc Nephrol"},{"key":"1585_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000348468","volume":"181","author":"H Ren","year":"2013","unstructured":"Ren H, Shen P, Li X, Pan X, Zhang Q, Feng X, et al. Treatment and prognosis of primary focal segmental glomerulosclerosis. Contrib Nephrol. 2013;181:109\u201318. \n                    https:\/\/doi.org\/10.1159\/000348468\n                    \n                  .","journal-title":"Contrib Nephrol"},{"issue":"4","key":"1585_CR9","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1681\/ASN.2004070593","volume":"16","author":"S Troyanov","year":"2005","unstructured":"Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry G. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol. 2005;16(4):1061\u20138. \n                    https:\/\/doi.org\/10.1681\/ASN.2004070593\n                    \n                  .","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1585_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/kisup.2012.10","volume":"2","author":"KU Eckardt","year":"2012","unstructured":"Eckardt KU, Kasiske BL. KDIGO clinical practice guideline for glomerulonephritis foreword. Kidney Int Suppl. 2012;2(2):140. \n                    https:\/\/doi.org\/10.1038\/kisup.2012.10\n                    \n                  .","journal-title":"Kidney Int Suppl"},{"issue":"25","key":"1585_CR11","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1056\/NEJMra1106556","volume":"365","author":"VD D\u2019Agati","year":"2011","unstructured":"D\u2019Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med. 2011;365(25):2398\u2013411. \n                    https:\/\/doi.org\/10.1056\/NEJMra1106556\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"1","key":"1585_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4103\/0377-4929.77322","volume":"54","author":"AK Prayaga","year":"2011","unstructured":"Prayaga AK, Anuradha SV, Manjusha Y, Uppin M, Rapur R, Dakshina Murthy KV. Morphologic evaluation of renal function using semi-quantitative method in primary nonproliferative glomerular diseases. Indian J Pathol Microbiol. 2011;54(1):42\u20136. \n                    https:\/\/doi.org\/10.4103\/0377-4929.77322\n                    \n                  .","journal-title":"Indian J Pathol Microbiol"},{"issue":"9","key":"1585_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"4","key":"1585_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.semnephrol.2012.06.009","volume":"32","author":"DO Wennmann","year":"2012","unstructured":"Wennmann DO, Hsu H-H, Pavenst\u00e4dt H. The Renin-Angiotensin-Aldosterone system in podocytes. Seminars Nephrol. 2012;32(4):377\u2013***84. \n                    https:\/\/doi.org\/10.1016\/j.semnephrol.2012.06.009\n                    \n                  .","journal-title":"Seminars Nephrol"},{"issue":"12","key":"1585_CR15","first-page":"1034","volume":"50","author":"X Li","year":"2011","unstructured":"Li X, Chen XD, Li ZX. The efficacy and safety of high-dose irbesartan in treatment of clinical proteinuria in patients with chronic kidney disease. Zhonghua Nei Ke Za Zhi. 2011;50 (12):1034\u20138.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"2","key":"1585_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1177\/1470320314543910","volume":"16","author":"J Zhang","year":"2015","unstructured":"Zhang J, Yanez D, Floege A, Lichtnekert J, Krofft RD, Liu ZH, et al. ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation. J Renin Angiotensin Aldosterone Syst. 2015;16(2):234\u201348. \n                    https:\/\/doi.org\/10.1177\/1470320314543910\n                    \n                  .","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"12","key":"1585_CR17","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1681\/ASN.2015080877","volume":"27","author":"J Lichtnekert","year":"2016","unstructured":"Lichtnekert J, Kaverina NV, Eng DG, Gross KW, Kutz JN, Pippin JW, et al. Renin-Angiotensin-Aldosterone system inhibition increases podocyte derivation from cells of renin lineage. J Am Soc Nephrol. 2016;27(12):3611\u201327.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1585_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/snep.2003.50020","volume":"23","author":"SM Korbet","year":"2003","unstructured":"Korbet SM. Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis. Semin Nephrol. 2003;23(2):219\u201328. \n                    https:\/\/doi.org\/10.1053\/snep.2003.50020\n                    \n                  .","journal-title":"Semin Nephrol"},{"issue":"4","key":"1585_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5935\/0101-2800.20150075","volume":"37","author":"LR Moura","year":"2015","unstructured":"Moura LR, Franco MF, Kirsztajn GM. Minimal change disease and focal segmental glomerulosclerosis in adults: response to steroids and risk of renal failure. J Bras Nefrol. 2015;37(4):475\u201380. \n                    https:\/\/doi.org\/10.5935\/0101-2800.20150075\n                    \n                  .","journal-title":"J Bras Nefrol"},{"issue":"4","key":"1585_CR20","first-page":"6902","volume":"10","author":"J Chen","year":"2017","unstructured":"Chen J, Chen M. A control study of the response from chinese patients with minimal change disease and focal segmental glomerulosclerosis to steroid therapy. Int J Clin Exp Med. 2017;10(4):6902\u20136.","journal-title":"Int J Clin Exp Med"},{"issue":"9","key":"1585_CR21","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1681\/ASN.2014050468","volume":"26","author":"L Li","year":"2015","unstructured":"Li L, Zhang T, Diao W, Jin F, Shi L, Meng J, et al. Role of myeloid-derived suppressor cells in glucocorticoid-mediated amelioration of FSGS. J Am Soc Nephrol. 2015;26(9):2183\u201397. \n                    https:\/\/doi.org\/10.1681\/ASN.2014050468\n                    \n                  .","journal-title":"J Am Soc Nephrol"},{"issue":"9156","key":"1585_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0140-6736(98)03563-6","volume":"353","author":"C Pozzi","year":"1999","unstructured":"Pozzi C, Bolasco PG, Fogazzi GB, Andrulli S, Altieri P, Ponticelli C, et al. Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet. 1999;353(9156):883\u20137.","journal-title":"Lancet"},{"issue":"3","key":"1585_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s10157-003-0236-0","volume":"7","author":"T Uzu","year":"2003","unstructured":"Uzu T, Harada T, Ko M, Yamato M, Takahara K, Yamauchi A. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria. Clin Exp Nephrol. 2003;7(3):210\u20134.","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"1585_CR24","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3109\/0886022X.2015.1033635","volume":"37","author":"S Mungan","year":"2015","unstructured":"Mungan S, Turkmen E, Aydin MC, Saglam AE, Baydar DE. Tip lesion variant of primary focal and segmental glomerulosclerosis: clinicopathological analysis of 20 cases. Ren Fail. 2015;37(5):858\u201365. \n                    https:\/\/doi.org\/10.3109\/0886022X.2015.1033635\n                    \n                   (Epub 2015 Apr 10).","journal-title":"Ren Fail"},{"issue":"3","key":"1585_CR25","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/ndt\/gfr430","volume":"27","author":"N Jafry","year":"2012","unstructured":"Jafry N, Ahmed E, Mubarak M, Kazi J, Akhter F. Raised serum creatinine at presentation does not adversely affect steroid response in primary focal segmental glomerulosclerosis in adults. Nephrol Dial Transpl. 2012;27(3):1101\u20136. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfr430\n                    \n                  .","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"1585_CR26","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.kint.2016.06.020","volume":"90","author":"MC Hogan","year":"2016","unstructured":"Hogan MC, Reich HN, Nelson PJ, Adler SG, Cattran DC, Appel GB, et al. The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseases. Kidney Int. 2016;90(5):1080\u20139. \n                    https:\/\/doi.org\/10.1016\/j.kint.2016.06.020\n                    \n                  .","journal-title":"Kidney Int"},{"issue":"1","key":"1585_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/1319-2442.148772","volume":"26","author":"G Swarnalatha","year":"2015","unstructured":"Swarnalatha G, Ram R, Ismal KM, Vali S, Sahay M, Dakshinamurty KV. Focal and segmental glomerulosclerosis: does prognosis vary with the variants? Saudi J Kidney Dis Transpl. 2015;26(1):173\u201381.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"6","key":"1585_CR28","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1681\/ASN.2006040347","volume":"18","author":"R Coppo","year":"2007","unstructured":"Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, et al. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol. 2007;18(6):1880\u20138.","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-018-1585-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1585-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1585-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:34:53Z","timestamp":1557794093000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-018-1585-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,14]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1585"],"URL":"https:\/\/doi.org\/10.1007\/s10157-018-1585-z","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,14]]},"assertion":[{"value":"9 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors have declared no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of Ruijin Hospital [(2017) Clinical Ethics Approval No. (154)] and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}